MCA
VCYT icon

Maryland Capital Advisors’s Veracyte VCYT Stock Holding History

Maryland Capital Advisors’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-112
Closed -$2K – 257
2022
Q3 		$2K Buy
+112
New +$2.52K ﹤0.01% 230

Other funds holding VCYT

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Maryland Capital Advisors's VCYT Position: Q4 2022 in Review

Maryland Capital Advisors sold out of Veracyte (VCYT) in Q4 2022, closing a stake of 112 shares — an estimated $2K sold.

Maryland Capital Advisors first reported a position in VCYT in Q3 2022 and held it in 1 quarter. The position peaked at $2K in Q3 2022. 223 funds tracked by Wall St. Rank hold VCYT as of Q4 2022.

  • Maryland Capital Advisors reported no remaining Veracyte position as of Q4 2022 after selling out during the quarter.
  • Maryland Capital Advisors sold 112 Veracyte shares in Q4 2022, an estimated $2K.
  • Maryland Capital Advisors first reported a position in Veracyte in Q3 2022 and held it in 1 quarter.
  • Maryland Capital Advisors's Veracyte position peaked at $2K in Q3 2022.
  • 223 funds tracked by Wall St. Rank held Veracyte as of Q4 2022.

Based on Maryland Capital Advisors's 13F filing for Q4 2022, filed 18 Jan 2023.